Literature DB >> 22969949

Correlation of polymorphisms of the vascular endothelial growth factor gene and the risk of lung cancer in an ethnic Han group of North China.

Yan Li1, Jing Liang, Xiaolin Liu, Hairong Liu, Beibei Yin, Junjuan Xiao, Zhenqiang Bi.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenic mediator. The present study investigated the relationship between genetic polymorphisms of VEGF and susceptibility to lung cancer in a Han ethnic group of North China. The genotypes in the -2578C and 936C loci of VEGF gene were determined using PCR-RFLP method in 150 patients with lung cancers and 150 healthy individuals. Software PHASE 1.0 was used to analyze the experimental data. The non-conditional logistic regression model was used to analyze the statistical association of genotypes and susceptibility in the two groups adjusted by multiple factors. VEGF polymorphisms were found to be a critical risk for the genetic susceptibility to lung cancers in the ethnic Han group of North China. SNP polymorphisms at the -2578C and 936C loci of the VEGF gene were detected by the RFLP-PCR method. High rates of a single-base C-to-A alteration at the -2578 locus and high rates of a single-base C-to-T alteration at the 936 locus of both alleles were correlated with the occurrence of lung cancer. The SNP markers at the -2578C and 936C loci of the VEGF gene may serve as biological markers of lung cancer.

Entities:  

Year:  2012        PMID: 22969949      PMCID: PMC3438852          DOI: 10.3892/etm.2012.453

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  17 in total

1.  Variation is the spice of life.

Authors:  L Kruglyak; D A Nickerson
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer.

Authors:  P Salven; T Ruotsalainen; K Mattson; H Joensuu
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

3.  Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.

Authors:  A Yuan; C J Yu; W J Chen; F Y Lin; S H Kuo; K T Luh; P C Yang
Journal:  Int J Cancer       Date:  2000-11-20       Impact factor: 7.396

4.  Expression of vascular endothelial growth factor in normal and tumour oral tissues assessed with different antibodies.

Authors:  R Baillie; K Harada; J Carlile; M Macluskey; S L Schor; A M Schor
Journal:  Histochem J       Date:  2001-05

5.  Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer.

Authors:  Y Oshika; M Nakamura; T Tokunaga; Y Ozeki; Y Fukushima; H Hatanaka; Y Abe; H Yamazaki; H Kijima; N Tamaoki; Y Ueyama
Journal:  Int J Oncol       Date:  1998-03       Impact factor: 5.650

6.  A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels.

Authors:  W Renner; S Kotschan; C Hoffmann; B Obermayer-Pietsch; E Pilger
Journal:  J Vasc Res       Date:  2000 Nov-Dec       Impact factor: 1.934

7.  Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.

Authors:  Qianren Jin; Kari Hemminki; Kerstin Enquist; Per Lenner; Ewa Grzybowska; Rüdiger Klaes; Roger Henriksson; Bowang Chen; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Jadwiga Rogozinska-Szczepka; Beata Utracka-Hutka; Göran Hallmans; Asta Försti
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

8.  New goals for the U.S. Human Genome Project: 1998-2003.

Authors:  F S Collins; A Patrinos; E Jordan; A Chakravarti; R Gesteland; L Walters
Journal:  Science       Date:  1998-10-23       Impact factor: 47.728

9.  Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.

Authors:  Eric J Jacobs; Heather Spencer Feigelson; Elizabeth B Bain; Kerri A Brady; Carmen Rodriguez; Victoria L Stevens; Alpa V Patel; Michael J Thun; Eugenia E Calle
Journal:  Breast Cancer Res       Date:  2006-04-13       Impact factor: 6.466

Review 10.  Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

Authors:  Kristy J Gotink; Henk M W Verheul
Journal:  Angiogenesis       Date:  2009-12-11       Impact factor: 9.596

View more
  11 in total

1.  Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.

Authors:  Quanchi Chen; Zifei Zhou; Liangcheng Shan; Yingqi Hua; Hui Zeng; Pengcheng Liu; Zhengdong Cai
Journal:  Biomed Rep       Date:  2014-07-15

2.  Vascular endothelial growth factor polymorphisms and lung cancer risk.

Authors:  Junli Fan; Weiguo Zhang; Caipeng Lei; Bin Qiao; Qin Liu; Qiang Chen; Hongduo Jiao; Leizhen Jiang; Shuo Cui; Jianmin Chen
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians.

Authors:  Ruhi Kapahi; Kamlesh Guleria; Vasudha Sambyal; Mridu Manjari; Meena Sudan; Manjit Singh Uppal; Neeti Rajan Singh
Journal:  Tumour Biol       Date:  2015-01-22

4.  Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies.

Authors:  Ning Song; Bao Liu; Jianling Wu; Rufang Zhang; Lin Duan; Wenshu He; Congmin Zhang
Journal:  Tumour Biol       Date:  2013-08-28

5.  Relationship between gene polymorphisms of two cytokine genes (TNF-α and IL-6) and occurring of lung cancers in the ethnic group Han of China.

Authors:  Jing Liang; Xiaolin Liu; Zhenqiang Bi; Beibei Yin; Junjuan Xiao; Hairong Liu; Yan Li
Journal:  Mol Biol Rep       Date:  2012-10-26       Impact factor: 2.316

6.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

7.  Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.

Authors:  Ling Lin; Kejian Cao; Wenhu Chen; Xufeng Pan; Heng Zhao
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

8.  Effects of internalized gold nanoparticles with respect to cytotoxicity and invasion activity in lung cancer cells.

Authors:  Zhengxia Liu; Yucheng Wu; Zhirui Guo; Ying Liu; Yujie Shen; Ping Zhou; Xiang Lu
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

9.  rs833061 and rs699947 on promoter gene of vascular endothelial growth factor (VEGF) and associated lung cancer susceptibility and survival: a meta-analysis.

Authors:  Junwei Tu; Saibin Wang; Jianping Zhao; Jingqian Zhu; Lin Sheng; Yijun Sheng; Huijun Chen; Jianghua Tian
Journal:  Med Sci Monit       Date:  2014-12-03

10.  Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis.

Authors:  Zai-Chun Deng; Chao Cao; Yi-Ming Yu; Hong-Ying Ma; Meng Ye
Journal:  Tumour Biol       Date:  2013-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.